Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

During 2011: Infrastructure at the UFS
2011-12-01

Video clips:

Health Sciences Building
Clinical Skills Centre
Economic Sciences and Lecture Hall Building
Teacher Education Building
Biotechnology Building


A publication in which the infrastructure developments at the UFS are portrayed, was published this year. This publication celebrates the enormous development projects undertaken.
 
Description: 2011 Infrastructure_part 1 Tags: 2011 Infrastructure_part 1  Description: 2011 Infrastructure_part 2 Tags: 2011 Infrastructure_part 2  Description: 2011 Infrastructure_part 3 Tags: 2011 Infrastructure_part 3 
Constructive change (part 1) Constructive change (part 2) Constructive change (part 3)

Much has been done this past year to improve the infrastructure of our Bloemfontein and Qwaqwa Campuses with several buildings being built, some renovated and improvements made. Attention was specifically given to the growing need for lecture hall facilities and office space.

Some of the developments on our Bloemfontein Campus include: a brand-new entrance in Nelson Mandela Drive; a Memorial for Women and a Botanical Garden; a building for teacher education opposite the UFS Sasol Library; a building for our Faculty of Health Sciences opposite the Francois Retief Building; a Clinical Skills Centre for Allied Health Professions (the first in the country); and a building for our Faculty of Economic and Management Sciences between the Flippie Groenewoud Building and Wynand Mouton Theatre.

On our Qwaqwa Campus a building for teacher education is being constructed and some of the laboratories were refurbished and upgraded. More student accommodation is also well underway. A village development of four housing units that will accommodate 1000 students will be constructed on our Bloemfontein Campus.
Renovations and extensions were also made to some of the existing buildings such as the Architecture Building, the Biotechnology Building, the Department of Chemistry, the Stef Coetzee Building, the foyer of the Odeion, the Wynand Mouton Theatre and the Callie Human Centre. A staff restaurant has also been established on the Bloemfontein Campus and the building of ‘Little Professors’, a nursery school, is well underway.
“A building not only signals value to the outside; it also builds value on the inside. That is why it is important to notice how space has been organised and allocated to enhance the building of a community and to give academics, students and communities a sense of belonging to the university,” says Prof. Jonathan Jansen, our Vice-Chancellor and Rector.

The funding for most of the projects was made possible with an infrastructural grant from the Department of Education and Training.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept